warfarin

Frage	Antworten
Explain mechanism of action of warfarin	warfarin exerts its effect by inhibiting Vitamin K dependent coagulation factors which are Factors II, VII, IX and X. It also inhibits the anticoagulant proteins C and S
Why is there a delay in onset of activity of warfarin?	it does not affect the clotting factors already there, we have to wait for those to clear before we see full effect of warfarin
why can we see a paradoxical hypercoagulable state during the first few days of therapy?	it inhibits the natural anticoagulants Protein C and S which have shorter half-lives and this depletion can resut in the hypercoagulable state; therefore patients should receive fast acting anticoagulants while transitioning to warfarin therapy
True or False Warfarin is administered orally and is a racemic mix of two isomers- the R isomer and the S isomer	True
Which of the isomers of warfarin is most potent in terms of anticoagulant effect?	the S isomer is 2 to 5 times more potent than the R isomer
True or False: Both isomers of warfarin are extensively bound to albumin and warfarin is extensivley metabolised in liver by several enzymes	True
True or False: genetic polymorphism in CYP450 enzymes can result in large inter-individual variation in dose requirements	True
True or False Warfarin follows linear kinetics	False
True or False Warfarin dose can be influenced by diet, drug-drug interactions and health status	True
How do we monitor warfarin	measure INR
What advice would you give patient regarding diet and warfarin?	need to keep their intake of Vitamin K containing foods relatively constant (avoid intake of Vit K rich foods)
What drug is used to reverse the effects of warfarin?	Vitamin K- also called phytomenadione
Of the following oral anticoagulants, which requires regular routine monitoring of anticoagulant effect? warfarin rivaroxaban dabigatran	warfarin
Which of the following drugs is administered as a prodrug? warfarin rivaroxaban dabigatran	dabigatran
Which of the following drugs does not have predictable pharmacokinetics? warfarin dabigatran rivaroxaban	warfarin
which of the oral anticoagulants has very low bioavalability (about 6%): warfarin rivaroxaban dabigatran etexilate	dabigatran etexilate
which of the following oral anticoagulants has long onset of action? warfarin dabigatran rivaroxaban	warfarin
which of the following oral anticoagulants has an antidote? warfarin rivaroxaban dabigatran	warfarin (the antidote is vitamin K)
which of the following oral anticoagulants is most likely to be affected by patient diet? rivaroxaban dabigatran warfarin	warfarin

Nächster

Beschreibung

Zusammenfassung der Ressource

ähnlicher Inhalt

	Erstellt von jenny schneider vor mehr als 9 Jahre